HOME Top Market Reports Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018

Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018

By: marketsandmarkets.com
Publishing Date: December 2013
Report Code: MD 2189

 

Enquiry Before Buying
Analyst Briefing  
purchase report
download pdf  request for customisation


The global microfluidics market is valued at an estimated $1.59 billion in 2013 and is expected to grow at a CAGR of 17.6% in the next five years. The high growth in this market can be attributed to the rising demand for POC devices, quick return on investments provided by microfluidics devices which helps in cost reduction, and miniaturization of microfluidic chips. The market is categorized into materials, products, and application segments. This report studies market estimations and trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices. Factors such as the difficulty in incorporating emerging microfluidic technologies into existing workflows and the complex and time consuming regulatory standards are hampering the growth of this market.

The market is expected to witness a high growth in the drug delivery devices segment, as these devices offer effective solutions for enhanced drug delivery through inhaler nozzles, micropumps, and micro needles. The micropumps market within the drug delivery devices segment is estimated to grow at the highest CAGR from 2013 to 2018; enhanced applications such as precise fluid control in nano and micro liter range are driving the growth of this market.

According to industry experts, the number of patent applications for microfluidics technology has increased from approximately 300 per year to around 4,000 per year. This increase in patent filings not only indicates the rising adoption of microfluidics technology across several applications but also the future opportunities in the competitive environment to capitalize the technology. Significant breakthroughs in nucleic acid analysis such as Human Genome Project (HGP), and enhanced efficacy in applications such as drug discovery and Point-of-Care diagnosis are resulting in new patent filings.

North America accounts for the largest share of the global market, followed by Europe. However, Asia is expected to grow at the highest CAGR during the study period. The growth in investments and lower labor and raw material costs in this region are some of the major factors having a positive impact on the growth of the microfluidics market in Asia. Asian markets such as China, Japan, India, and South Korea are the potential markets for investors in the near future.

Major players in the market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Caliper Life Sciences (PerkinElmer) (U.S.), Cepheid (U.S.), DanaherCorporation (U.S.), Life Technologies Corporation (U.S.), and Roche Diagnostics (Germany). A majority of companies in this market are from the U.S.

Scope of the Report

Microfluidics is defined as the science of designing, fabricating, and formulating products and processes that deal with low volumes of fluids in the range of nanoliters or picoliters. The technology evolved from MEMS (Micro Electro Mechanical Systems) devices and can replicate all the functions of its counterparts in various healthcare applications such as, drug delivery, Point-of-Care (POC), and clinical diagnostics. This study covers the materials, industries, and applications revenue markets for the global market. The global revenue generated from various microfluidics products used in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices is considered to estimate the market size.

The sales volume of microfluidics products is not in the scope of this report.

Global Microfluidics Market

The market has been segmented according to materials, industries, and applications.

  • By Material
    • Polymer-based Microfluidics
    • Glass-based Microfluidics
    • Silicon-based Microfluidics
    • Other Material-based Microfluidics
  • By Industry
    • Pharmaceuticals
      • Microfluidic Chips for Laboratory Analytics
        • Toxicity Screening
        • Proteomics Analysis
        • Gene Sequencing
        • Capillary Electrophoresis
      • Accurate Dispensing Devices
      • Microreactors for Drug Synthesis
    • In-Vitro Diagnostics
      • Clinical Diagnostics
      • Point-of-Care Testing
      • Environmental Testing
      • Industrial Testing
      • Agro Food Testing
    • Drug Delivery Devices
      • Inhaler Nozzles
      • Micro Needles
      • Micro Pumps
  • By Application
    • Drug Delivery
    • Industrial and Environmental
    • Analytical Devices
    • Pharmaceutical and Life Sciences Research
    • Point-of-Care Diagnostics
    • Clinical and Veterinary Diagnostics
  • By Geography
    • North America
    • Europe
    • Asia
    • RoW (Africa, LATAM, the MiddleEast, and the Pacific countries)

Table Of Contents
 
1 Introduction (Page No. - 21)
   1.1 Objectives of the Study
   1.2 Report Description
   1.3 Markets Covered
   1.4 Stakeholders
   1.5 Market Scope
   1.6 Research Methodology
       1.6.1 Market Size Estimation
       1.6.2 Market Crackdown & Data Triangulation
       1.6.3 Key Data Points From Primary Sources
       1.6.4 Key Data Points From Secondary Sources
       1.6.5 Assumptions

2 Executive Summary (Page No. - 34)

3 Premium Insights (Page No. - 37)
   3.1 Global Microfluidics Market, A Snapshot (2013)
   3.2 Market Dynamics
   3.3 Microfluidics Market, By Industry
   3.4 Microfluidics Market, By Applications
   3.5 Geographic Analysis & Materials Market

4 Market Overview (Page No. - 42)
   4.1 Introduction
   4.2 Market Segmentation
   4.3 Market Dynamics
       4.3.1 Drivers
             4.3.1.1 Rising Demand for Point-of-Care (Poc) Testing to Drive the Market
             4.3.1.2 Quick Return  on Investments Helping In Cost Reductions
             4.3.1.3 Microfluidic Chips Miniaturization Helps to Reduce Testing Time And Cost
       4.3.2 Restraints
             4.3.2.1 the Incorporation of Emerging Microfluidic Technology Into Existing Workflows Is Challenging
             4.3.2.2 Complex And Time Consuming Regulatory Standards to Lengthen the Approval Process
       4.3.3 Opportunities
             4.3.3.1 Growing Asian Market
             4.3.3.2 Shifting Trend towards Polymers Adoption
             4.3.3.3 Expanding Applications of Drug Delivery Technologies
       4.3.4 Trends
             4.3.4.1 Increasing Number of Patent Applications
       4.3.5 Challenges for Manufacturers
             4.3.5.1 Geometrical Issues
             4.3.5.2 Surface Chemistry Issues
       4.3.6 Winning Imperatives
             4.3.6.1 Standardization
             4.3.6.2 Compatibility
   4.4 Strategic Benchmarking
       4.4.1 Technology Integration & Product Enhancement
             4.4.1.1 Collaboration Between Fluidigm Corporation And Olink Bioscience
             4.4.1.2 Agreement Between Agilent Technologies, Inc. And Caliper Life Sciences, Inc.
             4.4.1.3 Agreement Between Perkinelmer And Genmark Diagnostics, Inc.
             4.4.1.4 Collaboration Between Roche Diagnostics And Immatics Biotechnologies GMBH
             4.4.1.5 Agreement Between Raindance Technologies And Myriad Genetics, Inc.

5 Microfluidics Market, By Material (Page No. - 55)
   5.1 Introduction
   5.2 Polymer-Based Microfluidics
   5.3 Glass-Based Microfluidics
   5.4 Silicon-Based Microfluidics
   5.5 Other Materials-Based (Paper & Ceramics) Microfluidics

6 Microfluidic Devices Market, By Industry (Page No. - 68)
   6.1 Introduction
   6.2 Pharmaceuticals
       6.2.1 Microfluidic Chips for Lab Analytics
             6.2.1.1 Toxicity Screening
             6.2.1.2 Proteomic Analysis
             6.2.1.3 Gene Sequencing
             6.2.1.4 Capillary Electrophoresis
       6.2.2 Accurate Dispensing Devices
       6.2.3 Microreactors for Drug Synthesis
   6.3 In-Vitro Diagnostics
       6.3.1 Clinical Diagnostics
       6.3.2 Point-of-Care (Poc)
       6.3.3 Environmental Testing
       6.3.4 Industrial Testing
       6.3.5 Agro Food Testing
   6.4 Drug Delivery Devices
       6.4.1 Inhaler Nozzles
       6.4.2 Microneedles
       6.4.3 Micropumps

7 Microfluidics Devices Market, By Applications (Page No. - 100)
   7.1 Introduction
   7.2 Drug Delivery
   7.3 Industrial & Environmental
   7.4 Analysis (Toxicity Screening, Proteomic Analysis & Gene Sequencing)
   7.5 Pharmaceutical & Life Science Research
   7.6 Point of Care Diagnostics
   7.7 Clinical & Veterinary Diagnostics

8 Geographic Analysis (Page No. - 112)
   8.1 Introduction
   8.2 North America
   8.3 Europe
   8.4 Asia
   8.5 Rest of the World (ROW)

9 Competitive Landscape (Page No. - 150)
   9.1 Introduction
   9.2 Mergers & Acquisitions
   9.3 Agreements, Partnerships, Collaborations, & Joint Ventures
   9.4 New Product Launches
   9.5 Expansion
   9.6 Approvals

10 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. - 158)
   10.1 Abbott Laboratories, Inc.
   10.2 Agilent Technologies
   10.3 Perkinelmer, Inc.
   10.4 Bartels Mikrotechnik GMBH
   10.5 Scienion AG
   10.6 Cepheid, Inc.
   10.7 Fluidigm Corporation
   10.8 Raindance Technologies
   10.9 Becton, Dickinson And Company 1 Becton Drive
   10.10 Bio-Rad Laboratories, Inc.
   10.11 Biofluidix GMBH
   10.12 Danaher Corporation
   10.13 Johnson & Johnson
   10.14 Life Technologies Corporation
   10.15 Microfluidic Chipshop GMBH
   10.16 Roche Diagnostics Limited
   10.17 Siemens Healthcare

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.
 
Competitive Developments (2011-2013)


List of Tables (72 Tables)

Table 1 Global Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 2 Global Microfluidic Materials Market: Revenue, By Type, 2011-2018 ($Million)
Table 3 Microfluidic Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 4 Polymer-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 5 Glass-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 6 Silicon-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 7 Paper & Ceramics-Based Materials Market: Revenue, By Geography, 2011-2018 ($Million)
Table 8 Microfluidics Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 9 Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 10 Microfluidics Pharmaceutical Products Market Revenue, By Geography, 2011-2018 ($Million)
Table 11 Microfluidic Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 12 Microfluidic Chips for Lab Analytics Market Revenue, By Geography, 2011-2018 ($Million)
Table 13 Microfluidic Chips for Toxicity Screening Market Revenue, By Geography, 2011-2018 ($Million)
Table 14 Microfluidic Chips for Proteomic Analysis Market Revenue, By Geography, 2011-2018 ($Million)
Table 15 Microfluidic Chips for Gene Sequencing Market Revenue, By Geography, 2011-2018 ($Million)
Table 16 Microfluidic Chips for Capillary Electrophoresis Market Revenue, By Geography, 2011-2018 ($Million)
Table 17 Microfluidic Accurate Dispensing Devices Market Revenue, By Geography, 2011-2018 ($Million)
Table 18 Microfluidic Microreactors for Drug Synthesis Market Revenue, By Geography, 2011-2018 ($Million)
Table 19 Microfluidic In-Vitro Diagnostics Market Revenue, By Products, 2011-2018 ($Million)
Table 20 Microfluidic In-Vitro Diagnostics Market Revenue, By Geography, 2011-2018 ($Million)
Table 21 Microfluidic Clinical Diagnostics Market Revenue, By Geography, 2011-2018 ($Million)
Table 22 Microfluidics Point of Care Market Revenue, By Geography, 2011-2018 ($Million)
Table 23 Microfluidic Environmental Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 24 Microfluidic Industrial Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 25 Microfluidic Agro Food Testing Market Revenue, By Geography, 2011-2018 ($Million)
Table 26 Microfluidic Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 27 Microfluidic Drug Delivery Devices Market Revenue, By Geography, 2011-2018 ($Million)
Table 28 Microfluidic Inhaler Nozzles Market Revenue, By Geography, 2011-2018 ($Million)
Table 29 Microfluidic Microneedles Market Revenue, By Geography, 2011-2018 ($Million)
Table 30 Microfluidic Micropumps Market Revenue, By Geography, 2011-2018 ($Million)
Table 31 Global Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 32 Microfluidics Drug Delivery Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 33 Microfluidics Industrial & Environmental Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 34 Microfluidics Analysis Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 35 Microfluidics Pharmaceutical & Life Science Research Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 36 Microfluidics Point of Care Diagnostics Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 37 Microfluidics Clinical & Veterinary Diagnostics Applications Market Revenue, By Geography, 2011-2018 ($Million)
Table 38 Global Microfluidics Market Revenue, By Geography, 2011-2018 ($Million)
Table 39 North America: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 40 North America: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 41 North America: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 42 North America: Microfluidic Chips for Lab Analytics Market Revenue, By Product, 2011-2018 ($Million)
Table 43 North America: Microfluidics Ivd Market Revenue, By Product, 2011-2018 ($Million)
Table 44 North America: Microfluidic Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 45 North America: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 46 Europe: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 47 Europe: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 48 Europe: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 49 Europe: Microfluidic Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 50 Europe: Microfluidics Ivd Market Revenue, By Products, 2011-2018 ($Million)
Table 51 Europe: Microfluidics Drug Delivery Devices Market Revenue, By Products, 2011-2018 ($Million)
Table 52 Europe: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 53 Asia: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 54 Asia: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 55 Asia: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 56 Asia: Microfluidics Chips for Lab Analytics Market Revenue, By Products, 2011-2018 ($Million)
Table 57 Asia: Microfluidics Ivd Market Revenue, By Products, 2011-2018 ($Million)
Table 58 Asia: Microfluidics Drug Delivery Devices Market Revenue, By Product, 2011-2018 ($Million)
Table 59 Asia: Microfluidics Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 60 ROW: Microfluidic Materials Market Revenue, By Type, 2011-2018 ($Million)
Table 61 ROW: Microfluidic Products Market Revenue, By Industry, 2011-2018 ($Million)
Table 62 ROW: Microfluidics Pharmaceutical Products Market Revenue, By Type, 2011-2018 ($Million)
Table 63 ROW: Microfluidic Chips for Lab Analytics Market Revenue, By Product, 2011-2018 ($Million)
Table 64 ROW: Microfluidics Ivd Market Revenue, By Product, 2011-2018 ($Million)
Table 65 ROW: Microfluidics Drug Delivery Devices Market Revenue, By Product, 2011-2018 ($Million)
Table 66 ROW: Microfluidic Applications Market Revenue, By Type, 2011-2018 ($Million)
Table 67 Mergers & Acquisitions, 2011-2013
Table 68 Agreements, Partnerships, Collaborations, & Joint Ventures, 2011-2013
Table 69 New Product Launches, 2011-2013
Table 70 Expansion, 2011-2012
Table 71 Approvals, 2013
Table 72 Life Technologies Corporation: Total Revenue, By Segment, 2010-2012 ($Million)


List of Figures (55 Figures)

Figure 1 Market Crackdown & Data Triangulation Methodology for Microfluidics Market
Figure 2 Market forecasting Model
Figure 3 Research Output: 360o Validation
Figure 4 Global Microfluidics Market, By Products, 2013-2018 ($Million)
Figure 5 Global Microfluidics Market, 2013
Figure 6 Microfluidics Market Dynamics
Figure 7 Microfluidics Market, By Industry, 2013-2018
Figure 8 Microfluidics Market, By Applications, 2013 Vs 2018
Figure 9 Microfluidics Market: Geographic Analysis, 2013 ($Million)
Figure 10 Microfluidics Market Segmentation
Figure 11 Technology Adoption & Product Enhancement
Figure 12 Microfluidics Market: By Materials, 2011-2018 (Market Size & Growth Rates)
Figure 13 Global Polymers Market Comparison, 2013 Vs 2018
Figure 14 Microfluidics Market, By Products, 2013-2018
Figure 15 Microfluidics Products Market Revenue, By Industry A Focus on Ivd (2013)
Figure 16 Global Microfluidics Market, By Applications, 2013-2018
Figure 17 Opportunity Matrix: Microfluidics Market, By Geography, 2013-2018
Figure 18 Key Growth Strategies in Microfluidics Market, 2011-2013
Figure 19 Abbott Laboratories, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 20 Abbott Laboratories, Inc.: Geographic Revenue Mix, 2012
Figure 21 Abbott Laboratories, Inc.: Business Revenue Mix, 2012
Figure 22 Abbott Laboratories, Inc.: Market Strategy, 2011-2013
Figure 23 Agilent Technologies: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 24 Agilent Technologies: Business Revenue Mix, 2012
Figure 25 Agilent Technologies: Market Strategy, 2010-2012
Figure 26 Perkinelmer, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Billion)
Figure 27 Perkinelmer, Inc.: Geographic Revenue Mix, 2012
Figure 28 Perkinelmer, Inc.: Business Revenue Mix, 2012
Figure 29 Perkinelmer, Inc.: Market Strategy, 2011-2012
Figure 30 Scienion AG: Market Strategy, 2012-2013
Figure 31 Cepheid, Inc.: Total Revenue And R&D Expenses, 2010-2012 ($Million)
Figure 32 Cepheid, Inc.: Geographic Revenue Mix, 2012
Figure 33 Cepheid, Inc.: Business Revenue Mix, 2012
Figure 34 Cepheid, Inc.: Market Strategy, 2011-2013
Figure 35 Fluidigm Corporation: Total Revenue And R&D Expenses, 2010-2012 ($Million)
Figure 36 Fluidigm Corporation: Geographic Revenue Mix, 2012
Figure 37 Fluidigm Corporation: Business Revenue Mix, 2012
Figure 38 Fluidigm Corporation: Market Strategy, 2011-2013
Figure 39 Raindance Technologies: Market Strategy, 2011-2013
Figure 40 Becton, Dickinson And Company: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 41 BD Diagnostics: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 42 Becton, Dickinson And Company: Market Strategy, 2011-2013
Figure 43 Bio-Rad Laboratories, Inc.: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 44 Bio-Rad Laboratories, Inc.: Market Srategy, 2011-2013
Figure 45 Danaher Corporation: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 46 Danaher Corporation: Market Strategy, 2011-2013
Figure 47 Johnson & Johnson: Total Revenue, By Segment, 2010-2012 ($Milllion)
Figure 48 Johnson & Johnson: Diagnostics Franchise Revenue, 2010-2012 ($Million)
Figure 49 Johnson & Johnson: Market Strategy, 2011-2013
Figure 50 Life Technologies Corporation: Market Strategy, 2012-2013
Figure 51 Roche Holdings: Diagnostics Revenue, By Segment, 2010-2012 ($Million)
Figure 52 Roche Holdings: Diagnostics Revenue, By Geography, 2010-2012 ($Million)
Figure 53 Roche Holdings: Market Strategy, 2011-2013
Figure 54 Siemens Ag: Total Revenue, By Segment, 2010-2012 ($Million)
Figure 55 Siemens Healthcare: Market Strategy, 2011-2013

    The microfluidics market is segmented based on materials, products, and applications. This report studies market trends for the aforementioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices.

    The market is expected to grow at a strong CAGR during the study period. This is due to factors such as the rising demand for POC devices, quick return on investments provided by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips. However, factors such as difficulty in incorporation of emerging microfluidic technologies into existing workflows and complex and time consuming regulatory standards are hampering the growth of this market.

    The estimated value of the market was calculated based on the materials, (industry) products, and applications revenue. Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on industry, the market is classified into pharmaceutical, in-vitro diagnostics, and drug delivery devices. The pharmaceutical segment is categorized into microfluidics chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The microfluidics chips for lab analytics segment is further classified into toxicity screening, proteomic analysis, gene sequencing, and capillary electrophoresis. In-vitro diagnostics is further segmented into clinical diagnostics, Point-of-Care diagnostics, environmental testing, industrial testing, and agro food testing. The drug delivery devices market is categorized into inhaler nozzles, micro needles, and micro pumps.

    Based on applications, the market is categorized into six applications, namely, drug delivery, industrial and environmental, analytical devices, pharmaceutical and life science research, Point-of-Care diagnostics, and clinical and veterinary diagnostics. The Point-of-Care diagnostics segment commands the largest share of the global applications market. It is expected to grow at a strong CAGR during the study period. The large share of this segment is attributed to the increased adoption of microfluidics in Point-of-Care diagnostics by major diagnostic companies such as Roche Diagnostics (Switzerland), Becton Dickinson and Company (U.S.), Abbott Laboratories (U.S.), and Cepheid (U.S.).

    North America dominates the market, accounting for around one-third of the share. The leading market share of the North American region is attributed to the presence of a large number of major manufacturers such as, Abbott Laboratories, Agilent Technologies, Caliper Life Sciences (PerkinElmer), and Johnson & Johnson, in this region. Additionally, the rising adoption of microfluidics technology and the increasing rate of new product launches in the North American region are the favorable factors driving the market growth.

    Global Microfluidics Market Scenario

    Microfluidics Market

    Source: Annual Reports, SEC Filings, Expert Interviews, and MarketsandMarkets Analysis

    Custom Market Research Services

    We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

    Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

    Connect With Us

    Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
    Live Chat Support


    US : 1-888-600-6441
    UK : 44-800-368-9399

    Search reports